Investigating the Human Immune Response to Ixodes scapularis Tick Bites
Investigating the Human Immune Response to Ixodes scapularis Tick Bites
批准号:
10927972
负责人:
ADRIANA R MARQUES
金额:
$53.78万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
Anaplasma phagocytophilumAnaplasmosisAnimal ModelAnimalsArthropodsBabesia microtiBabesiosisBacteriologyBasophilsBiological AssayBiological ProcessBiopsyBlack-legged TickBloodBlood PlateletsBody WeightBorrelia burgdorferiBorrelia mayoniiBorrelia miyamotoiCase StudyCaviaCellsCessation of lifeClinicalClinical ResearchCoagulation ProcessDiagnosisDiseaseEhrlichiaEhrlichiosisExposure toFlow CytometryFutureGenesHistopathologyHumanImmune responseImmunityIndividualInfectionInnate Immune ResponseIxodesIxodidaeLaboratoriesLifeLyme DiseaseMalariaMeasuresMolecularMolecular BiologyMonitorNational Institute of Allergy and Infectious DiseaseNatureOryctolagus cuniculusParaffinParticipantPersonsPowassan virusProcessProteinsProteomicsPruritusPublic HealthRNAResearchResistanceResolutionRoleSalivarySalivary ProteinsSkinStandardizationSystemTechnologyTestingTick-Borne DiseasesTick-Borne EncephalitisTicksTimeUnited StatesVaccine DesignVirusXenodiagnosisadaptive immune responseanti-tick vaccineclinical developmentdifferential expressionexperiencefeedinghuman diseaseimmunoregulationmolecular vectornano-stringnext generation sequencingpathogenpreservationresponseskin irritationtick bitetick feedingtick salivatranscriptomicstransmission processvector
中文摘要
在美国,蜱传疾病(tbd)是一个严重的公共卫生问题,2004年至2016年报告的病例数量增加了一倍多。鹿蜱是至少7种引起人类疾病的病原体的媒介:莱姆病(伯氏疏螺旋体和马氏疏螺旋体)、无形体病(嗜吞噬细胞无形体)、巴贝斯虫病(微小巴贝斯虫)、宫莫氏疏螺旋体病(宫莫氏疏螺旋体)、埃利希体病(白克莱氏埃利希体)和蜱传脑炎(鹿蜱病毒/波瓦桑病毒)。莱姆病占报告的蜱传疾病病例的80%以上,据估计,美国每年诊断和治疗的莱姆病病例超过47.6万例。
英文摘要
Tick-borne diseases (TBDs) are a serious public health problem in the United States, with the number of reported cases more than doubling during 2004 to 2016. The deer tick (Ixodes scapularis) is the vector of at least 7 pathogens that cause human diseases: Lyme disease (Borrelia burgdorferi and Borrelia mayonii), anaplasmosis (Anaplasma phagocytophilum), babesiosis (Babesia microti), Borrelia miyamotoi disease (Borrelia miyamotoi), ehrlichiosis (Ehrlichia muris eauclairensis), and tick-borne encephalitis (deer tick virus/Powassan virus). Lyme disease accounts for more than 80% of the reported cases of tickborne diseases, with estimates of over 476,000 cases of Lyme disease been diagnosed and treated per year in the US.
Ticks are obligate blood-feeding arthropods and require a blood meal at every active life stage. To acquire its blood meal, an ixodid tick must remain attached to the skin of a vertebrate host and complete its multi-day feeding process. Tick saliva is composed of a large variety of proteins that are differentially expressed throughout the process of tick feeding. Some of these proteins have anti-clotting, anti-platelet, vasodilatory, and immunomodulatory activities that allow successful feeding and pathogen transmission. The skin response to tick salivary proteins has been implicated in tick rejection as certain animals (e.g., rabbits, guinea pigs) that are repeatedly infested develop an immune response against tick proteins. Resistance to tick bites is manifested by reduced numbers and body weights of engorged ticks or tick death in subsequent infestations in these animal models and consequently protection against Borrelia burgdorferi transmission.
Most people will not feel a tick bite, as tick bites do not tend to cause itching or immediate skin irritation. But people who have had many tick bites can become sensitized to tick bites over time, and this can protect against Lyme disease. Little is known about the nature of the protective immune response. We have combined our expertise to study the response to tick bites in a well standardized clinical setting to identify critical aspects of the human innate and adaptive immune responses in skin and blood following exposure to uninfected Ixodes scapularis ticks; and monitor the acquisition of a tick-associated skin immunity, including itch. This research could lead to the identification of tick salivary proteins that are targets of host immunity and might serve as targets for an anti-tick vaccine.
The Lyme Disease Studies Unit at NIAID has been involved for many years in studies to examine the use of larval I. scapularis ticks in xenodiagnosis of B. burgdorferi infection and have extensive experience with placement of larval I. scapularis ticks in humans. The Vector Molecular Biology Section at the Laboratory of Malaria and Vector Research, and the Tick-Pathogen Transmission Unit, at the Laboratory of Bacteriology at Rocky Mountain Laboratories (RML), have extensive experience in working with the tick Ixodes scapularis, the isolation of Ixodes salivary components, molecular aspects of tick salivary proteins and the understanding of guinea pig immune responses to tick exposure, tick rejection and the role tick salivary proteins on tick rejection.
Major accomplishments of the past year are the continuation of accrual of participants into the Major accomplishments of the past year are the continuation of accrual of participants into the study, which is now 65% completed. As planned in the clinical study, we continue to collect blood and skin biopsies from the participants at different time points after tick attachment. RNA from biopsies were extracted and RNA Illumina next generation sequencing is being performed. Biopsies have also been processed and preserved in paraffin for histopathology and guidance of the spatial analysis. Ticks fed on participants are being collect for RNA and protein extraction, which will be used for transcriptomic and proteomic analysis. We developed a basophil activation assay using flow cytometry to measure the activation of basophil to tick saliva in the blood of individuals exposed to tick bites. For feasibility, we tested one set of biopsies from normal skin, and skin bitten by ticks at time 24h and 48h by single cell spatial gene analysis using CosMx technology by Nanostring. This system gives single-cell resolution spatial transcriptomics and proteomics that will further our understanding of the biological processes involved in the host response.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Trial Of Varicella Vaccine For The Prevention Of Herpes
-
批准号:7303840
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ADRIANA R MARQUES
-
依托单位:
Trial Of Varicella Vaccine For The Prevention Of Herpes Zoster
-
批准号:7592246
-
项目类别:
-
资助金额:$17.25万
-
财政年份:--
-
负责人:ADRIANA R MARQUES
-
依托单位:
Assessment Of Patients With Lyme Infection
-
批准号:6986002
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ADRIANA R MARQUES
-
依托单位:
Assessment Of Patients With Lyme Infection
-
批准号:7194103
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ADRIANA R MARQUES
-
依托单位:
Trial Of Varicella Vaccine For The Prevention Of Herpes Zoster
-
批准号:7732549
-
项目类别:
-
资助金额:$11.25万
-
财政年份:--
-
负责人:ADRIANA R MARQUES
-
依托单位:
Assessment Of Patients With Lyme Infection
-
批准号:6669570
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ADRIANA R MARQUES
-
依托单位:
Assessment Of Patients With Borrelia Infection
-
批准号:10692041
-
项目类别:
-
资助金额:$69.43万
-
财政年份:--
-
负责人:ADRIANA R MARQUES
-
依托单位:
Assessment Of Patients With Borrelia Infection
-
批准号:10927751
-
项目类别:
-
资助金额:$99.87万
-
财政年份:--
-
负责人:ADRIANA R MARQUES
-
依托单位:
Trial Of Varicella Vaccine For The Prevention Of Herpes Zoster
-
批准号:8156920
-
项目类别:
-
资助金额:$10.68万
-
财政年份:--
-
负责人:ADRIANA R MARQUES
-
依托单位:
Novel Therapies for Herpes Simplex Virus Infections
-
批准号:6099147
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ADRIANA R MARQUES
-
依托单位:
Assessment Of Patients With Borrelia Infection
-
批准号:8555803
-
项目类别:
-
资助金额:$29.31万
-
财政年份:--
-
负责人:ADRIANA R MARQUES
-
依托单位:
Assessment Of Patients With Borrelia Infection
-
批准号:8336099
-
项目类别:
-
资助金额:$26.52万
-
财政年份:--
-
负责人:ADRIANA R MARQUES
-
依托单位:
Trial Of Varicella Vaccine For The Prevention Of Herpes Zoster
-
批准号:8946341
-
项目类别:
-
资助金额:$18.27万
-
财政年份:--
-
负责人:ADRIANA R MARQUES
-
依托单位:
Assessment Of Patients With Lyme Infection
-
批准号:6808669
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ADRIANA R MARQUES
-
依托单位:
Evaluation of the Inflammatory Responses Evoked by SARS
-
批准号:6809408
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ADRIANA R MARQUES
-
依托单位:
Trial Of Varicella Vaccine For The Prevention Of Herpes Zoster
-
批准号:8336140
-
项目类别:
-
资助金额:$26.52万
-
财政年份:--
-
负责人:ADRIANA R MARQUES
-
依托单位:
Assessment Of Patients With Borrelia Infection
-
批准号:7732502
-
项目类别:
-
资助金额:$7.5万
-
财政年份:--
-
负责人:ADRIANA R MARQUES
-
依托单位:
TREATMENT OF CHRONIC HEPATITIS B VIRUS INFECTION
-
批准号:6099005
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ADRIANA R MARQUES
-
依托单位:
COMPREHENSIVE ASSESSMENT OF PTS WITH SUSPECTED CHRONIC LYME INFECTION
-
批准号:6099028
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ADRIANA R MARQUES
-
依托单位:
Novel Therapies For Herpes Simplex Virus Infections
-
批准号:6809052
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ADRIANA R MARQUES
-
依托单位:
海外基金